1171 related articles for article (PubMed ID: 2416504)
1. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
2. [Iatrogenic torsade de pointes induced by thioridazine].
Paoloni P; Ciliberti D; Blasi N; Capone P
Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
[TBL] [Abstract][Full Text] [Related]
3. Disopyramide-induced Torsade de Pointes.
Tzivoni D; Keren A; Stern S; Gottlieb S
Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
[TBL] [Abstract][Full Text] [Related]
4. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
Skanes AC; Morton BC; Green MS; Tang AS
Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
[TBL] [Abstract][Full Text] [Related]
5. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
6. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
Ophoff N; Toker Y
Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
[TBL] [Abstract][Full Text] [Related]
7. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
8. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
[TBL] [Abstract][Full Text] [Related]
9. Torsades de pointes, a common arrhythmia, induced by medication.
Ko PT; Gulamhusein S; Kostuk WJ; Klein GJ
Can Med Assoc J; 1982 Sep; 127(5):368-72. PubMed ID: 7104914
[TBL] [Abstract][Full Text] [Related]
10. [Torsade de pointes caused by tricyclic antidepressive agents. Description of a clinical case].
Casazza F; Fiorista F; Rustici A; Brambilla G
G Ital Cardiol; 1986 Dec; 16(12):1058-61. PubMed ID: 3556944
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
12. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
Schlienger RG; Haefeli WE; Lüscher TF
Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
[TBL] [Abstract][Full Text] [Related]
13. Torsade de pointe. Report of 18 cases.
Chalak W; Taha A; Araoya M; Rifaat M
J Med Liban; 1993; 41(2):62-8; discussion 68-9. PubMed ID: 8057345
[TBL] [Abstract][Full Text] [Related]
14. A case series of drug-induced long QT syndrome and Torsade de Pointes.
Tong KL; Lau YS; Teo WS
Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
[TBL] [Abstract][Full Text] [Related]
15. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
Assimes TL; Malcolm I
Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
[TBL] [Abstract][Full Text] [Related]
16. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F
Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
[TBL] [Abstract][Full Text] [Related]
19. Torsade de pointes: the clinical considerations.
Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
[TBL] [Abstract][Full Text] [Related]
20. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
